Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$8.21 - $18.59 $614,723 - $1.39 Million
-74,875 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$11.33 - $19.81 $848,333 - $1.48 Million
74,875 New
74,875 $1.39 Million
Q3 2020

Nov 12, 2020

SELL
$11.33 - $19.81 $410,712 - $718,112
-36,250 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$4.2 - $15.45 $152,250 - $560,062
36,250 New
36,250 $413,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.